iSpecimen Inc.ISPCNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank0
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-2.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -100.00% |
| Q2 2025 | -1.66% |
| Q1 2025 | -42.69% |
| Q4 2024 | 0.00% |
| Q3 2024 | -100.00% |
| Q2 2024 | -0.00% |
| Q1 2024 | -5.77% |
| Q4 2023 | 5.02% |
| Q3 2023 | 9.31% |
| Q2 2023 | 1.04% |
| Q1 2023 | 12.70% |
| Q4 2022 | -1.63% |
| Q3 2022 | 18.41% |
| Q2 2022 | 20.50% |
| Q1 2022 | 0.95% |
| Q4 2021 | -3.87% |
| Q3 2021 | 50.24% |
| Q2 2021 | -11.75% |
| Q1 2021 | 39.07% |
| Q4 2020 | -28.69% |
| Q3 2020 | 41.76% |
| Q2 2020 | -31.66% |
| Q1 2020 | 98.99% |
| Q4 2019 | -29.21% |
| Q3 2019 | 0.00% |